SEC Form 4 research
| Issuer | Jasper Therapeutics, Inc. |
|---|---|
| Tickers | JSPR, AMHCU, AMHC |
| Reporting owners | 53 |
| Officers and directors | 7 |
| Last public filing | 2026-08-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-04 | 2026-07-31 | WIGGANS THOMAS G | A | 7,500 | $0 | Not reported |
| 2026-08-04 | 2026-07-31 | Lucas Svetlana | A | 7,500 | $0 | Not reported |
| 2026-08-04 | 2026-07-31 | Crutcher Patrick J | A | 7,500 | $0 | Not reported |
| 2026-08-04 | 2026-07-31 | EMSTER KURT VON | A | 7,500 | $0 | Not reported |
| 2026-08-04 | 2026-07-31 | Shizuru Judith Anne | A | 7,500 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.